Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manuel de Lera Ruiz

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Medicinal Chemistry|May 1, 2015
Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical IndicationsManuel de Lera Ruiz, Richard L Kraus
Journal of Medicinal Chemistry|October 30, 2013
Adenosine A2A receptor as a drug discovery targetManuel de Lera Ruiz, Yeon-Hee Lim, Junying Zheng
Bioorganic & Medicinal Chemistry Letters|September 17, 2013
Bicyclic and tricyclic heterocycle derivatives as histamine H3 receptor antagonists for the treatment of obesityManuel de Lera Ruiz, Junying Zheng, Michael Y Berlin, et al.
The Journal of Organic Chemistry|May 25, 2019
Synthesis of a CGRP Receptor Antagonist via an Asymmetric Synthesis of 3-Fluoro-4-aminopiperidineCarmela Molinaro, Eric M Phillips, Bangping Xiang, et al.
Structure (London, England : 1993)|April 23, 2022
Basis for drug selectivity of plasmepsin IX and X inhibition in Plasmodium falciparum and vivaxAnthony N Hodder, Janni Christensen, Stephen Scally, et al.
ACS Medicinal Chemistry Letters|November 17, 2022
The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of MalariaManuel de Lera Ruiz, Paola Favuzza, Zhuyan Guo, et al.
Chemmedchem|December 4, 2014
Discovery of MK-8970: an acetal carbonate prodrug of raltegravir with enhanced colonic absorptionAbbas M Walji, Rosa I Sanchez, Sophie-Dorothee Clas, et al.
Cell Host & Microbe|February 29, 2020
Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life CyclePaola Favuzza, Manuel de Lera Ruiz, Jennifer K Thompson, et al.
Ebiomedicine|December 7, 2025
MK-7602: a potent multi-stage dual-targeting antimalarialPaola Favuzza, Josephine Palandri, Manuel de Lera Ruiz, et al.
Journal of Medicinal Chemistry|February 16, 2024
Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine MimicValerie W Shurtleff, Mark E Layton, Craig A Parish, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Medicinal Chemistry|May 1, 2015
Voltage-Gated Sodium Channels: Structure, Function, Pharmacology, and Clinical IndicationsManuel de Lera Ruiz, Richard L Kraus
Journal of Medicinal Chemistry|October 30, 2013
Adenosine A2A receptor as a drug discovery targetManuel de Lera Ruiz, Yeon-Hee Lim, Junying Zheng
Bioorganic & Medicinal Chemistry Letters|September 17, 2013
Bicyclic and tricyclic heterocycle derivatives as histamine H3 receptor antagonists for the treatment of obesityManuel de Lera Ruiz, Junying Zheng, Michael Y Berlin, et al.
The Journal of Organic Chemistry|May 25, 2019
Synthesis of a CGRP Receptor Antagonist via an Asymmetric Synthesis of 3-Fluoro-4-aminopiperidineCarmela Molinaro, Eric M Phillips, Bangping Xiang, et al.
Structure (London, England : 1993)|April 23, 2022
Basis for drug selectivity of plasmepsin IX and X inhibition in Plasmodium falciparum and vivaxAnthony N Hodder, Janni Christensen, Stephen Scally, et al.
ACS Medicinal Chemistry Letters|November 17, 2022
The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of MalariaManuel de Lera Ruiz, Paola Favuzza, Zhuyan Guo, et al.
Chemmedchem|December 4, 2014
Discovery of MK-8970: an acetal carbonate prodrug of raltegravir with enhanced colonic absorptionAbbas M Walji, Rosa I Sanchez, Sophie-Dorothee Clas, et al.
Cell Host & Microbe|February 29, 2020
Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life CyclePaola Favuzza, Manuel de Lera Ruiz, Jennifer K Thompson, et al.
Ebiomedicine|December 7, 2025
MK-7602: a potent multi-stage dual-targeting antimalarialPaola Favuzza, Josephine Palandri, Manuel de Lera Ruiz, et al.
Journal of Medicinal Chemistry|February 16, 2024
Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine MimicValerie W Shurtleff, Mark E Layton, Craig A Parish, et al.
Pageof 1